BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06682988-completion@plaintrial.com
DTSTAMP:20261028T093748Z
DTSTART;VALUE=DATE:202803
SUMMARY:A Study to Assess Adverse Events and Change in Disease Activity in 
 Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovaria
 n\, Primary Peritoneal\, or Fallopian Tube Cancers With High Folate Recept
 or-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab S
 oravtansine — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06682988
URL:https://plaintrial.com/trial/NCT06682988
END:VEVENT
END:VCALENDAR